Dynamical generation of wormholes with charged fluids in quadratic Palatini gravity

The dynamical generation of wormholes within an extension of General Relativity (GR) containing (Planck's scale-suppressed) Ricci-squared terms is considered. The theory is formulated assuming the metric and connection to be independent (Palatini formalism) and is probed using a charged null fluid as a matter source. This has the following effect: starting from Minkowski space, when the flux is active the metric becomes a charged Vaidya-type one, and once the flux is switched off the metric settles down into a static configuration such that far from the Planck scale the geometry is virtually indistinguishable from that of the standard Reissner-Nordstr\"om solution of GR. However, the innermost region undergoes significant changes, as the GR singularity is generically replaced by a wormhole structure. Such a structure becomes completely regular for a certain charge-to-mass ratio. Moreover, the nontrivial topology of the wormhole allows to define a charge in terms of lines of force trapped in the topology such that the density of lines flowing across the wormhole throat becomes a universal constant. To the light of our results we comment on the physical significance of curvature divergences in this theory and the topology change issue, which support the view that space-time could have a foam-like microstructure pervaded by wormholes generated by quantum gravitational effects.Comment: 14 pages, 3 figures, revtex4-1 style. New content added on section VI. Other minor corrections introduced. Final version to appear in Phys. Rev.

Propiedades psicométricas de la escala de procrastinación en el trabajo en colaboradores de clínicas de salud ocupacional de Chiclayo, 2018

La procrastinación laboral implica aplazar tareas por otras actividades que resultan más interesantes, generando retrasos e incumplimientos de los objetivos, baja el nivel de productividad y crea una imagen negativa tanto personal como empresarial. Por ello, es relevante contar con un instrumento válido y confiable adaptado al contexto peruano para medir la variable. Los objetivos específicos de la investigación fueron estimar la validez de contenido, validez de constructo, confiabilidad y establecer los puntos de corte y la confiabilidad de estos. Los participantes fueron 126 colaboradores de Clínicas de Salud Ocupacional de Chiclayo, mayores de 18 años. El diseño y tipo de investigación fue no experimental, instrumental. El análisis de validez se realizó mediante un análisis factorial exploratorio y la fiabilidad se estimó utilizando los métodos de consistencia interna (alfa de cronbach y omega). Los resultados indicaron que la escala consta de dos factores (militarización y cyberpereza), los que explican un ,586 de la varianza. Asimismo, la dimensión de militarización cuenta con un coeficiente alfa de cronbach de ,840 y un coeficiente de omega de ,848; mientras que la dimensión de cyberpereza cuenta con ,773 y ,800 respectivamente. Se establecieron los puntos de corte, encontrando que estos son confiables con un coeficiente K2 de Livingston > ,90

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase

Planck scale physics and topology change through an exactly solvable model

We consider the collapse of a charged radiation fluid in a Planck-suppressed quadratic extension of General Relativity (GR) formulated à la Palatini. We obtain exact analytical solutions that extend the charged Vaidya-type solution of GR, which allows to explore in detail new physics at the Planck scale. Starting from Minkowski space, we find that the collapsing fluid generates wormholes supported by the electric field. We discuss the relevance of our findings in relation to the quantum foam structure of space–time and the meaning of curvature divergences in this theory.F.S.N.L. acknowledges financial support of the Fundação para a Ciência e Tecnologia through an Investigador FCT Research contract, with reference IF/00859/2012, funded by FCT/MCTES (Portugal), and grants CERN/FP/123615/2011 and CERN/FP/123618/2011. G.J.O. is supported by the Spanish grant FIS2011-29813-C02-02, the Consolider Program CPANPHY-1205388, and the JAE-doc program of the Spanish Research Council (CSIC). D.R.G. is supported by CNPq (Brazilian agency) through project No. 561069/2010-7 and thanks the hospitality and partial support of the Theoretical Physics Department of the University of Valencia. This work has also been supported by CNPq through project No. 301137/2014-5

Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adults

Background: the associations of cause-specific mortality with alcohol consumption have been studied mainly in higher-income countries. We relate alcohol consumption to mortality in Cuba.Methods: in 1996-2002, 146 556 adults were recruited into a prospective study from the general population in five areas of Cuba. Participants were interviewed, measured and followed up by electronic linkage to national death registries until January 1, 2017. After excluding all with missing data or chronic disease at recruitment, Cox regression (adjusted for age, sex, province, education, and smoking) was used to relate mortality rate ratios (RRs) at ages 35–79 years to alcohol consumption. RRs were corrected for long-term variability in alcohol consumption using repeat measures among 20 593 participants resurveyed in 2006-08.Findings: after exclusions, there were 120 623 participants aged 35-79 years (mean age 52 [SD 12]; 67 694 [56%] women). At recruitment, 22 670 (43%) men and 9490 (14%) women were current alcohol drinkers, with 15 433 (29%) men and 3054 (5%) women drinking at least weekly; most alcohol consumption was from rum. All-cause mortality was positively and continuously associated with weekly alcohol consumption: each additional 35cl bottle of rum per week (110g of pure alcohol) was associated with ∼10% higher risk of all-cause mortality (RR 1.08 [95%CI 1.05-1.11]). The major causes of excess mortality in weekly drinkers were cancer, vascular disease, and external causes. Non-drinkers had ∼10% higher risk (RR 1.11 [1.09-1.14]) of all-cause mortality than those in the lowest category of weekly alcohol consumption (<1 bottle/week), but this association was almost completely attenuated on exclusion of early follow-up.Interpretation: in this large prospective study in Cuba, weekly alcohol consumption was continuously related to premature mortality. Reverse causality is likely to account for much of the apparent excess risk among non-drinkers. The findings support limits to alcohol consumption that are lower than present recommendations in Cuba.Funding: Medical Research Council, British Heart Foundation, Cancer Research UK, CDC Foundation (with support from Amgen

Body-mass index, blood pressure, diabetes and cardiovascular mortality in Cuba: prospective study of 146,556 participants

Background: cardiovascular disease accounts for about one-third of all premature deaths (ie, age < 70) in Cuba. Yet, the relevance of major risk factors, including systolic blood pressure (SBP), diabetes, and body-mass index (BMI), to cardiovascular mortality in this population remains unclear.Methods: in 1996–2002, 146,556 adults were recruited from the general population in five areas of Cuba. Participants were interviewed, measured (height, weight and blood pressure) and followed up by electronic linkage to national death registries until Jan 1, 2017; in 2006–08, 24,345 participants were resurveyed. After excluding all with missing data, cardiovascular disease at recruitment, and those who died in the first 5 years, Cox regression (adjusted for age, sex, education, smoking, alcohol and, where appropriate, BMI) was used to relate cardiovascular mortality rate ratios (RRs) at ages 35–79 years to SBP, diabetes and BMI; RR were corrected for regression dilution to give associations with long-term average (ie, ‘usual’) levels of SBP and BMI.Results: after exclusions, there were 125,939 participants (mean age 53 [SD12]; 55% women). Mean SBP was 124 mmHg (SD15), 5% had diabetes, and mean BMI was 24.2 kg/m2 (SD3.6); mean SBP and diabetes prevalence at recruitment were both strongly related to BMI. During follow-up, there were 4112 cardiovascular deaths (2032 ischaemic heart disease, 832 stroke, and 1248 other). Cardiovascular mortality was positively associated with SBP (>=120 mmHg), diabetes, and BMI (>=22.5 kg/m2): 20 mmHg higher usual SBP about doubled cardiovascular mortality (RR 2.02, 95%CI 1.88–2.18]), as did diabetes (2.15, 1.95–2.37), and 10 kg/m2 higher usual BMI (1.92, 1.64–2.25). RR were similar in men and in women. The association with BMI and cardiovascular mortality was almost completely attenuated following adjustment for the mediating effect of SBP. Elevated SBP (>=120 mmHg), diabetes and raised BMI (>=22.5 kg/m2) accounted for 27%, 14%, and 16% of cardiovascular deaths, respectively.Conclusions: this large prospective study provides direct evidence for the effects of these major risk factors on cardiovascular mortality in Cuba. Despite comparatively low levels of these risk factors by international standards, the strength of their association with cardiovascular death means they nevertheless exert a substantial impact on premature mortality in Cuba

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. Methods: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping riociguat treatment. Primary safety outcomes were adverse events (AEs) and serious adverse events (SAEs) coded using Medical Dictionary for Regulatory Activities preferred terms and System Organ Classes version 21.0, collected during routine clinic visits and collated via case report forms. Results: In total, 956 patients with CTEPH were included in the analysis. The most common AEs in these patients were peripheral edema/edema (11.7%), dizziness (7.5%), right ventricular (RV)/cardiac failure (7.7%), and pneumonia (5.0%). The most common SAEs were RV/cardiac failure (7.4%), pneumonia (4.1%), dyspnea (3.6%), and syncope (2.5%). Exposure-adjusted rates of hemoptysis/pulmonary hemorrhage and hypotension were low and comparable to those in the long-term extension study of riociguat (Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase–Stimulator Trial [CHEST-2]). Conclusion: Data from EXPERT show that in patients with CTEPH, the safety of riociguat in routine practice was consistent with the known safety profile of the drug, and no new safety concerns were identified

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. Methods: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping riociguat treatment. Primary safety outcomes were adverse events (AEs) and serious adverse events (SAEs) coded using Medical Dictionary for Regulatory Activities preferred terms and System Organ Classes version 21.0, collected during routine clinic visits and collated via case report forms. Results: In total, 956 patients with CTEPH were included in the analysis. The most common AEs in these patients were peripheral edema/edema (11.7%), dizziness (7.5%), right ventricular (RV)/cardiac failure (7.7%), and pneumonia (5.0%). The most common SAEs were RV/cardiac failure (7.4%), pneumonia (4.1%), dyspnea (3.6%), and syncope (2.5%). Exposure-adjusted rates of hemoptysis/pulmonary hemorrhage and hypotension were low and comparable to those in the long-term extension study of riociguat (Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase–Stimulator Trial [CHEST-2]). Conclusion: Data from EXPERT show that in patients with CTEPH, the safety of riociguat in routine practice was consistent with the known safety profile of the drug, and no new safety concerns were identified